Department of Preventive Dental Sciences, College of Dentistry, Taibah University, AlMadinah AlMunawwarah, Saudi Arabia; Centre for Epidemiology Versus Arthritis, The University of Manchester, Manchester, UK.
Department of Nursing, Faculty of Health and Education, Manchester Metropolitan University, UK; Division of Population Health, Health Services Research & Primary Care, University of Manchester, UK.
Arch Gerontol Geriatr. 2023 Aug;111:104995. doi: 10.1016/j.archger.2023.104995. Epub 2023 Mar 11.
Frailty is a syndrome characterised by decline in functional ability and increasing vulnerability to disease and associated with adverse outcomes. Several established methods exist for assessing frailty. This scoping review aims to characterise the development and validation of frailty indices based on laboratory test results (FI-Lab) and to assess their utility.
Studies were included in the review if they included data concerning the development and/or testing an FI-Lab using the deficit accumulation method. Studies were identified using PubMed/MEDLINE, Embase (Elsevier), OpenGrey and Google Scholar from 2010 to 2021. Two reviewers independently screened all abstracts, and those that met the inclusion criteria were reviewed in detail. Data extracted included details about the study characteristics, number, type and coding of laboratory variables included, validation, and outcomes. A narrative synthesis of the available evidence was adopted.
The search yielded 915 articles, of which 29 studies were included. In general, 89% of studies were conducted after 2016 and 51% in a hospital-based setting. The number of variables included in FI-Labs ranged from 13 to 77, and 51% included some non-laboratory variables in their indices, with pulse and blood pressure being the most frequent. The validity of FI-Lab was demonstrated through change with age, correlation with established frailty indices and association with adverse health outcomes. The most frequent outcome studied was mortality (79% of the studies), with FI-Lab associated with increased mortality in all but one. Other outcomes studied included self-reported health, institutionalisation, and activities of daily living. The effect of combining the FI-Lab with a non-laboratory-based FI was assessed in 7 studies with a marginal increase in predictive ability.
Frailty indices constructed based on the assessment of laboratory variables, appear to be a valid measure of frailty and robust to the choice of variables included.
衰弱是一种以功能能力下降和对疾病的易感性增加为特征的综合征,与不良结局有关。目前已经有几种评估衰弱的方法。本范围综述旨在描述基于实验室检查结果的衰弱指数(FI-Lab)的开发和验证,并评估其效用。
本综述纳入了使用缺陷积累法开发和/或测试 FI-Lab 的研究。研究通过 PubMed/MEDLINE、Embase(Elsevier)、OpenGrey 和 Google Scholar 从 2010 年到 2021 年进行检索。两名审查员独立筛选所有摘要,符合纳入标准的摘要进行详细审查。提取的数据包括研究特征、纳入实验室变量的数量、类型和编码、验证和结局的详细信息。采用叙述性综合方法对现有证据进行分析。
检索到 915 篇文章,其中 29 篇研究符合纳入标准。一般来说,89%的研究是在 2016 年后进行的,51%的研究是在医院环境中进行的。FI-Lab 中纳入的变量数量从 13 个到 77 个不等,51%的指数纳入了一些非实验室变量,其中脉搏和血压是最常见的。FI-Lab 的有效性通过与年龄变化、与已建立的衰弱指数的相关性以及与不良健康结局的相关性得到了证明。研究中最常见的结局是死亡率(79%的研究),除了一项研究外,FI-Lab 与死亡率增加相关。其他研究的结局包括自我报告的健康状况、机构化和日常生活活动。有 7 项研究评估了将 FI-Lab 与非实验室为基础的 FI 相结合的效果,发现预测能力略有提高。
基于实验室检查结果评估构建的衰弱指数似乎是一种有效的衰弱评估方法,并且对纳入的变量选择具有稳健性。